Avoro Capital Advisors LLC - 30 Sep 2025 SCHEDULE 13G Report for Centessa Pharmaceuticals plc Ordinary shares, nominal value 0.002 GBP per share (CNTA)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: Centessa Pharmaceuticals plc Ordinary shares, nominal value 0.002 GBP per share
Symbol: CNTA
Shares outstanding: 134,095,285 shares
Disclosed Ownership: 10,808,080 shares
Ownership: 8.1%
Form type: SCHEDULE 13G
Filing time: 14 Nov 2025, 09:05:31 UTC
Date of event: 30 Sep 2025
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	8.1%	10,808,080	10,808,080	0	/s/ Scott Epstein	Scott Epstein, Chief Operating Officer & Chief Compliance Officer
Behzad Aghazadeh	8.1%	10,808,080	10,808,080	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually